CRUCELL HOLLAND BV
Crucell N.V. is a global biopharmaceutical company focused on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases. Its vaccines are sold in public and private markets worldwide. Crucell's core portfolio includes a vaccine against hepatitis B, a fully-liquid vaccine against five important childhood diseases and a virosome-adjuvanted vaccine against influenza. Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on the market.
CRUCELL HOLLAND BV
Industry:
Biotechnology Health Care Therapeutics
Founded:
1993-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.crucell.com
Total Employee:
5001+
Status:
Closed
Contact:
31 71 519 9100
Email Addresses:
[email protected]
Total Funding:
443 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon IPv6 Cloudflare DNS Amazon Route 53 Amazon CloudFront Amazon Ireland Region Verizon
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Johnson & Johnson
Johnson & Johnson investment in Post-IPO Equity - Crucell Holland BV
Atlas Venture
Atlas Venture investment in Seed Round - Crucell Holland BV
Official Site Inspections
http://www.crucell.com
- Host name: ec2-52-209-188-36.eu-west-1.compute.amazonaws.com
- IP address: 52.209.188.36
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
